Sign in

CIK 0001515673

  • Large accelerated filer

Ultragenyx Pharmaceutical Inc.

Sign in to watch
Ticker
RARE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
272546083
Phone
+1 415-483-8800
Business address
60 LEVERONI COURT, NOVATO, CA, 94949
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$127,561
in 3 filings, $17K under 10b5-1 plans

Net −$127,561. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-04-19 KAKKIS EMIL D President & CEO Shares withheld for taxes −851 $58.57 $50K 653,649
2020-04-19 Huizenga Theodore Alan SVP, Controller and PAO Shares withheld for taxes −140 $58.57 $8K 19,818
2020-04-19 Huang Dennis Karl EVP & Chief Tech Ops Officer Shares withheld for taxes −248 $58.57 $15K 35,227
2020-04-19 Harris Erik EVP & Chief Commercial Officer Shares withheld for taxes −210 $58.57 $12K 24,362
2020-03-12 KAKKIS EMIL D President & CEO Option exercise +83,167 $3.01 $250K 587,967
2020-03-12 KAKKIS EMIL D President & CEO Option exercise +66,533 $3.01 $200K 654,500
2020-03-12 KAKKIS EMIL D President & CEO Option exercise · Warrant (Right to Buy) −83,167 0
2020-03-12 KAKKIS EMIL D President & CEO Option exercise · Warrant (Right to Buy) −66,533 0
2020-03-01 Huizenga Theodore Alan SVP, Controller and PAO Grant or award +4,400 19,958
2020-03-01 Huizenga Theodore Alan SVP, Controller and PAO Grant or award · Stock Option (Right to Buy) +13,280 13,280
2020-03-01 Harris Erik EVP & Chief Commercial Officer Grant or award +7,800 22,109
2020-03-01 Harris Erik EVP & Chief Commercial Officer Grant or award +3,287 25,396
2020-03-01 Harris Erik EVP & Chief Commercial Officer Shares withheld for taxes −824 $56.08 $46K 24,572
2020-03-01 Harris Erik EVP & Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +22,000 22,000
2020-03-01 Parschauer Karah Herdman EVP and General Counsel Grant or award +7,800 26,884
2020-03-01 Parschauer Karah Herdman EVP and General Counsel Grant or award +5,634 32,518
2020-03-01 Parschauer Karah Herdman EVP and General Counsel Shares withheld for taxes −2,118 $56.08 $119K 30,400
2020-03-01 Parschauer Karah Herdman EVP and General Counsel Grant or award · Stock Option (Right to Buy) +22,000 22,000
2020-03-01 KAKKIS EMIL D President & CEO Grant or award +17,000 492,914
2020-03-01 KAKKIS EMIL D President & CEO Grant or award +18,782 511,696

Page 30 of 32 · 632 trades